UNRESECTABLE LEIOMYOSARCOMA
Clinical trials for UNRESECTABLE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-phase trial tests whether combining two drugs—peposertib and a low-dose form of the chemotherapy doxorubicin—is safe and effective for people with advanced sarcomas that have spread or can't be removed by surgery. About 30 adults with specific sarcoma types will receiv…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for rare cancer: drug targets tumor growth
Disease control Recruiting nowThis study tests a drug called zanzalintinib (XL092) in people with advanced leiomyosarcoma, a rare cancer that has spread or cannot be removed by surgery. The drug works by blocking signals that help cancer cells grow. About 29 participants will take the drug to see if it can sl…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC